MDSC and tumor-promoting neutrophils clearly differentiate into divergent cell types, as MDSCs have reduced expression of CD16 and CD62L and increased expression of Arg-1, CD66B, and CD11b [38,39]. This evidence concerns the gene ARG1 and neoplasm.